BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  ZOLL Enrolls First Patient in Groundbreaking SSCORE Commercial Registry at Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, MN)

  September 24, 2024

   · 

  5 min read
• Press Releases

  QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database

  September 24, 2024

   · 

  8 min read
• Press Releases

  BioVie Inc. Announces Pricing of Public Offering

  September 24, 2024

   · 

  5 min read
• Press Releases

  Nature Reviews Highlights Significant Successes of Antibiotic Collaboration and Calls for Sustainable R&D Funding Schemes

  September 24, 2024

   · 

  8 min read
• Press Releases

  LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy

  September 24, 2024

   · 

  3 min read
• Press Releases

  Japan’s Ministry of Health, Labour and Welfare Approves PADCEV™ (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Radically Unresectable Urothelial Carcinoma

  September 24, 2024

   · 

  11 min read
• Press Releases

  AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy

  September 24, 2024

   · 

  3 min read
• Drug Development

  Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea

  September 24, 2024

   · 

  4 min read
• Press Releases

  In-Vitro Toxicology Testing Market is Projected to Reach US$ 30.06 Bn by 2033

  September 24, 2024

   · 

  1 min read